Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Patient Registry Software Market: Market Segments: By Type of Registry (Disease Registries, Health Service Registries and Product Registries); By Software (Stand-alone and Integrated); By End User (Hospitals, Government Organizations and Third-Party Administrators (TPAs), Pharmaceutical, Biotechnology, Medical Device Companies and Other); and Region – Global Analysis by Market Size, Share & Trends for 2014 – 2020 and Forecasts to 2030
Product Overview
Patient registry software (PRS) is a computerized database containing personal, medical, social and financial information that is recorded by or by healthcare professionals. Registries may provide researchers and health care providers with important epidemiological data for rare or chronic diseases, such as incidence and prevalence, signs and seriousness of the disease.
Market Highlights
Patient Registry Software Market is expected to project a notable CAGR of 14.7% in 2030.
Patient Registry Software Market to surpass USD 2.9 billion by 2030 from USD 968 Million in 2019 at a CAGR of 14.7% throughout the forecast period, i.e., 2020-30. An increased incidence of cancer and other chronic disorders is projected to propel the growth of the global market for patient registry software.
Patient Registry Software Market: Segments
Product Registries segment to grow with the highest CAGR of 4.1% during 2020-30
Patient Registry Software Market is segmented by type of registry as Disease Registries, Health Service Registries and Product Registries. Based on registry type, disease registry segment is the largest segment of the market for Patient Registry Software owing to the increasing demand to integrate the healthcare system and to curb the disease burden is driving the segment. In order to create new medications, these registries are also useful in screening patients for clinical trials.
Patient Registry Software Market: Market Dynamics
Drivers
Rising Adoption of Electronic Health Records
Aadoption of electronic health records (EHRs) and other HCIT solutions is growing globally, which is considered a positive sign for the software industry for patient registries. This is because for many EHR products, patient registry software functionality is included or is available as an add-on. Authorities in many countries are focused on increasing the implementation in their healthcare systems of EHR solutions to help increase the provision of healthcare services.
Restrain
Privacy and Data Security-related Concerns
Concerns about privacy abuses such as data theft, are associated with all types of medical information technology (IT). Also, due to data protection issues, widespread adoption of registry applications has been restrained. Intensifying security controls is an achievable task for suppliers delivering these services, but these security controls come at the expense of ease of operation, thus undermining the platform's performance.
Patient Registry Software Market: Key Players
• Dacima Software Inc
• Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence and SWOT Analysis.
•
• FIGmd Inc.
• Global Vision Technologies Inc.
• Image Trend Inc.
• IQVIA
• Liasion Technologies
• McKensson Corporation
• Syneos Health
• Velos Inc
Patient Registry Software Market: Regions
Patient Registry Software Market is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, APAC and MENA.
Patient Registry Software Market in North America held the largest market share of XX.X% in the year 2019 and is anticipated to continue its dominance over the forecast period. The growth of the market in this region is driven by an increasing target population coupled with increasing disease prevalence and the need for population-based registries. In addition, growing government initiatives are making this region a major contributor to the patient registry software market. Companies are constantly trying to develop better user-interactive software in order to make patient registry software more user-friendly and interactive for clinical research. Over the forecast period, Asia Pacific is projected to show profitable growth. In the past few years, the adoption of electronic medical records has been increasing. The key factors driving the market in the area are growing pressure to curb medical errors, frequent hospital visits, increased diagnostic errors coupled with increasing co-morbidity incidences, and the ageing population. In addition, supportive government initiatives, particularly in Japan, China and South Korea, boost the growth of the patient registry software.
Patient Registry Software Market report also contains analysis on:
Patient Registry Software Market Segments:
By Type of Registry:
• Disease Registries
• Health Service Registries
• Product Registries
By Software:
• Stand-alone Software
• Integrated Software
By End User:
• Government Organizations & Third-Party Administrators (TPAs)
• Hospitals and Medical Practices
• Private Payers
• Pharmaceutical, Biotechnology, and Medical Device Companies
• Research Centers
• Patient Registry Software Market Dynamics
• Patient Registry Software Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies Involved in the Market
• Value Chain of the Market
• Market Drivers and Restraints
FAQs on Patient Registry Software Market
· Which segment is anticipated to hold the largest market share
· At what CAGR is the market anticipated to grow between 2020 and 2030
· Who are the key players in the Patient Registry Software Market
· What could be the challenging factors in the growth of Patient Registry Software Market
· What are the growth drivers for the Patient Registry Software Market
Contents
1. Executive Summary
2. Patient Registry Software Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Macro-Economic Indicators
6. Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix
8. Recent Development, Policies & Regulatory Landscape
9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. Patient Registry Software Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. Patient Registry Software Market
11.1. Market Size & forecast, 2019A-2030F
11.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.1.2. By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12. Patient Registry Software: Market Segmentation
12.1. By Regions
12.1.1. North America:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.2. Europe:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.3. Asia-Pacific:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.4. MEA:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.5. Latin America:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2. By Type of Registry: Market Share (2020-2030F)
12.2.1. Disease Registries, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.2. Health Service Registries, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.3. Product Registries, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3 By Software: Market Share (2020-2030F)
12.3.1. Stand-alone Software, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3.2. Integrated Software, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.4 By End User: Market Share (2020-2030F)
12.4.1. Government Organizations & Third-Party Administrators (TPAs), By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.4.2. Hospitals and Medical Practices, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.4.3. Private Payers, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.4.4. Pharmaceutical, Biotechnology, and Medical Device Companies, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.4.5. Research Centers, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
13. Company Profile
13.1.1. Dacima Software Inc.
13.1.2. Company Overview
13.1.3. Company Total Revenue (Financials)
13.1.4. Market Potential
13.1.5. Global Presence
13.1.6. Key Performance Indicators
13.1.7. SWOT Analysis
13.1.8. Product Launch
13.2. FIGmd Inc.
13.3. Global Vision Technologies Inc.
13.4. Image Trend Inc.
13.5. IQVIA
13.6. Liasion Technologies
13.7. McKensson Corporation
13.8. Syneos Health
13.9. Velos Inc
14 Consultant Recommendation
**The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
Research Methodology:
Patient Registry Software Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|